Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,138 | -541 | -2,936 | -2,212 | -1,653 |
| Depreciation Amortization | 138 | 69 | 281 | 211 | 141 |
| Other Working Capital | -104 | 27 | -9 | -52 | -17 |
| Other Operating Activity | 99 | 34 | 439 | 296 | 198 |
| Operating Cash Flow | $-1,005 | $-411 | $-2,225 | $-1,757 | $-1,330 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -6 | -7 | 2 | 4 |
| Investing Cash Flow | $-6 | $-6 | $-7 | $2 | $4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 455 | 459 | 2,001 | 1,288 | 1,251 |
| Financing Cash Flow | $455 | $459 | $2,001 | $1,288 | $1,251 |
| Beginning Cash Position | 707 | 707 | 938 | 938 | 938 |
| End Cash Position | 152 | 750 | 707 | 470 | 862 |
| Net Cash Flow | $-556 | $43 | $-231 | $-468 | $-76 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,005 | -411 | -2,225 | -1,757 | -1,330 |
| Capital Expenditure | -6 | -6 | -12 | -3 | -2 |
| Free Cash Flow | -1,011 | -417 | -2,237 | -1,760 | -1,332 |